Singapore markets closed

agilon health, inc. (AGL)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
5.13-0.20 (-3.75%)
At close: 04:00PM EDT
5.15 +0.02 (+0.39%)
Pre-market: 04:39AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 2.11B
Enterprise value 1.67B
Trailing P/E N/A
Forward P/E 204.08
PEG ratio (5-yr expected) N/A
Price/sales (ttm)0.49
Price/book (mrq)3.19
Enterprise value/revenue 0.39
Enterprise value/EBITDA -9.96

Trading information

Stock price history

Beta (5Y monthly) 0.50
52-week change 3-78.86%
S&P500 52-week change 321.08%
52-week high 326.75
52-week low 34.41
50-day moving average 35.62
200-day moving average 312.26

Share statistics

Avg vol (3-month) 34.99M
Avg vol (10-day) 34.6M
Shares outstanding 5411.06M
Implied shares outstanding 6427.08M
Float 8304.09M
% held by insiders 11.55%
% held by institutions 1109.62%
Shares short (15 Apr 2024) 446.02M
Short ratio (15 Apr 2024) 410.27
Short % of float (15 Apr 2024) 444.59%
Short % of shares outstanding (15 Apr 2024) 411.20%
Shares short (prior month 15 Mar 2024) 446.96M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -6.08%
Operating margin (ttm)-15.56%

Management effectiveness

Return on assets (ttm)-8.44%
Return on equity (ttm)-22.95%

Income statement

Revenue (ttm)4.32B
Revenue per share (ttm)10.56
Quarterly revenue growth (yoy)53.10%
Gross profit (ttm)N/A
EBITDA -216.09M
Net income avi to common (ttm)-195.05M
Diluted EPS (ttm)-0.48
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)488.34M
Total cash per share (mrq)1.19
Total debt (mrq)52.31M
Total debt/equity (mrq)7.91%
Current ratio (mrq)1.51
Book value per share (mrq)1.63

Cash flow statement

Operating cash flow (ttm)-156.2M
Levered free cash flow (ttm)-70.94M